Gemifloxacin is a potent, broad-spectrum fluoroquinolone antibacterial agent primarily indicated for the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate community-acquired… Read more
![Chemical structure of (7-[3-(Aminomethyl)-4-oxopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid monomethanesulfonate)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3085683-01-5-7-3-Aminomethyl-4-oxopyrrolidin-1-yl-1-cyclopropyl-6-fluoro-4-oxo-14-dihydro-18-naphthyridine-3-carboxylic-acid-monomethanesulfonate.png&w=3840&q=75)

![Chemical structure of 7-[3-(Aminomethyl)-4-hydroxypyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid monomethanesulfonate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7-3-Aminomethyl-4-hydroxypyrrolidin-1-yl-1-cyclopropyl-6-fluoro-4-oxo-14-dihydro-18-naphthyridine-3-carboxylic-acid-monomethanesulfonate.png&w=3840&q=75)





Gemifloxacin is a potent, broad-spectrum fluoroquinolone antibacterial agent primarily indicated for the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate community-acquired pneumonia. To ensure rigorous quality control and accurate analytical testing of this medication, laboratories utilize a comprehensive range of reference materials. This category provides access to high-quality gemifloxacin reference standards, which are essential for verifying the identity, strength, and purity of pharmaceutical formulations. The selection includes essential synthetic impurities, such as related compounds B and C, which are critical for impurity profiling and method validation. Additionally, researchers can source metabolites, such as acyl glucuronide, and stable isotope-labelled compounds for use as internal standards in mass spectrometry and pharmacokinetic studies. These specialized compounds support reliable development and compliance monitoring throughout the pharmaceutical lifecycle.